The 'small for size' liver syndrome

Current Opinion in Critical Care

Volumn 11, Issue 2, 2005, Pages 150-155

  Tucker, O N ^a   Heaton, Nigel ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Future remnant liver; Hepatectomy; Liver transplantation; Liver volume; Living donor liver transplantation; Small for size syndrome

Indexed keywords

ARTIFICIAL EMBOLISM; BLOOD CLOTTING DISORDER; BODY WEIGHT; EVALUATION; HEPATIC ARTERY; HEPATOGRAPHY; HUMAN; IMAGING SYSTEM; LIVER DYSFUNCTION; LIVER FUNCTION; LIVER FUNCTION TEST; LIVER GRAFT; LIVER PROTECTION; LIVER REGENERATION; LIVER RESECTION; LIVER SIZE; LIVER TRANSPLANTATION; LIVER WEIGHT; OUTCOMES RESEARCH; PORTAL HYPERTENSION; PORTAL VEIN; PREDICTION; PREOPERATIVE EVALUATION; REVIEW; RISK FACTOR; SMALL FOR SIZE SYNDROME; SURGICAL TECHNIQUE;

ADULT; HEPATECTOMY; HEPATIC INSUFFICIENCY; HUMANS; HYPERTENSION, PORTAL; LIVER; LIVER TRANSPLANTATION; ORGAN SIZE; SYNDROME;

EID: 16844385667     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccx.0000157080.11117.45     Document Type: Review

References (66)

1. Kiuchi T, Kasahara M, Uryuhara K, et al. Impact of graft size mismatching on graft prognosis in liver transplantation from living donors. Transplantation 1999; 67:321-327.
2. Heaton N. Small-for-size liver syndrome after auxiliary and split liver transplantation: donor selection. Liver Transpl 2003; 9:S26-S28.
3. Urata K, Kawasaki S, Matsunami H, et al. Calculation of child and adult standard liver volume for liver transplantation. Hepatology 1995; 21:1317-1321.
4. Kubota K, Makuuchi M, Kusaka K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26:1176-1181.
5. Lin XZ, Sun YN, Liu YH, et al. Liver volume in patients with or without chronic liver diseases. Hepatogastroenterology 1998; 45:1069-1074.
6. Heinemann A, Wischhusen F, Puschel K, Rogiers X. Standard liver volume in the Caucasian population. Liver Transpl Surg 1999; 5:366-368.
7. Urata K, Hashikura Y, Ikegami T, et al. Standard liver volume in adults. Transplant Proc 2000; 32:2093-2094.
8. Vauthey JN, Chaoui A, Do KA, et al. Standardized measurement of the future liver remnant prior to extended liver resection: methodology and clinical associations. Surgery 2000; 127:512-519.
9. Vauthey JN, Abdalla EK, Doherty DA, et al. Body surface area and body weight predict total liver volume in Western adults. Liver Transpl 2002; 8:233-240.
10. Abdalla EK, Denys A, Chevalier P, et al. Total and segmental liver volume variations: implications for liver surgery. Surgery 2004; 135:404-410.
11. Azoulay D, Castaing D, Smail A, et al. Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. Ann Surg 2000; 231:480-486.
12. Higashiyama H, Yamaguchi T, Mori K, et al. Graft size assessment by preoperative computed tomography in living related partial liver transplantation. Br J Surg 1993; 80:489-492.
13. Lo CM, Fan ST, Liu CL, et al. Minimum graft size for successful living donor liver transplantation. Transplantation 1999; 68:1112-1116.
14. Kawasaki S, Makuuchi M, Matsunami H, et al. Living related liver transplantation in adults. Ann Surg 1998; 227:269-274.
15. Heaton N, Rela M. Auxiliary liver transplantation. In Transplantation of the liver. Edited by Maddrey WC, Schiff ER, Sorrell MF. Philadelphia: Lipincott Williams and Wilkins; 2001.
16. Abdalla EK, Barnett CC, Doherty D, et al. Extended hepatectomy in patients with hepatobiliary malignancies with and without preoperative portal vein embolization. Arch Surg 2002; 137:675-680.
17. Shoup M, Gonen M, D'Angelica M, et al. Volumetric analysis predicts hepatic dysfunction in patients undergoing major liver resection. J Gastrointest Surg 2003; 7:325-330. A retrospective study analysing 126 consecutive patients undergoing liver resection for colorectal metastasis. The percentage of liver remaining was more specific in predicting hepatic dysfunction than the anatomic extent of resection. Ninety percent of patients with ≤25% of liver remaining developed hepatic dysfunction.
18. Farges O, Malassagne B, Flejou JF, et al. Risk of major liver resection in patients with underlying chronic liver disease: a reappraisal. Ann Surg 1999; 229:210-215.
19. Vauthey JN, Pawlik TM, Abdalla EK, et al. Is extended hepatectomy for hepatobiliary malignancy justified? Ann Surg 2004; 239:722-730.
20. Kokudo N, Imamura H, Sugawara Y, et al. Surgery for multiple hepatic colorectal metastases. J Hepatobiliary Pancreat Surg 2004; 11:84-91.
21. Jarnagin WR, Gonen M, Fong Y, et al. Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 2002; 236:397-406.
22. Bennink RJ, Dinant S, Erdogan D, et al. Preoperative assessment of postoperative remnant liver function using hepatobiliary scintigraphy. J Nucl Med 2004; 45:965-971.
23. Takeuchi E, Nimura Y, Nagino M, et al. Human hepatocyte growth factor in bile: an indicator of posthepatectomy liver function in patients with biliary tract carcinoma. Hepatology 1997; 26:1092-1099.
24. Maeda A, Nagino M, Takeuchi E, et al. Interleukin 6 in bile as an indicator of liver function after hepatectomy in patients with biliary tract carcinoma. Br J Surg 1999; 86:458-464.
25. Kurumiya Y, Nagino M, Nozawa K, et al. Biliary bile acid concentration is a simple and reliable indicator for liver function after hepatobiliary resection for biliary cancer. Surgery 2003; 133:512-520.
26. Sato Y, Ichida T, Yamamoto S, et al. Shear stress theory and small-for-size graft in adult living related liver transplantation. Transplant Proc 2003; 35:78.
27. Kooby DA, Fong Y, Suriawinata A, et al. Impact of steatosis on perioperative outcome following hepatic resection. J Gastrointest Surg 2003; 7:1034-1044. A retrospective review of 325 patients with steatosis and 160 control patients with normal livers who underwent hepatectomy over a 10-year period. The presence of marked steatosis was an independent predictor of complications but did not have a significant impact on 60-day mortality.
28. Abdalla EK, Hicks ME, Vauthey JN. Portal vein embolization: rationale, technique and future prospects. Br J Surg 2001; 88:165-175.
29. Yigitler C, Farges O, Kianmanesh R, et al. The small remnant liver after major liver resection: how common and how relevant? Liver Transpl 2003; 9:S18-S25.
30. Tanaka H, Hirohashi K, Kubo S, et al. Preoperative portal vein embolization improves prognosis after right hepatectomy for hepatocellular carcinoma in patients with impaired hepatic function. Br J Surg 2000; 87:879-882.
31. Hemming AW, Reed AI, Howard RJ, et al. Preoperative portal vein embolization for extended hepatectomy. Ann Surg 2003; 237:686-691. A retrospective review of 60 patients with hepatobiliary malignancy from 1996-2002 analysing the effect of preoperative PVE. An increase in the remnant liver volume by preoperative PVE in patients with estimated postresection volumes of <25% is recommended to reduce postoperative liver dysfunction.
32. Ijichi M, Makuuchi M, Imamura H, Takayama T. Portal embolization relieves persistent jaundice after complete biliary drainage. Surgery 2001; 130: 116-118.
33. Uesaka K, Nimura Y, Nagino M. Changes in hepatic lobar function after right portal vein embolization. An appraisal by biliary indocyanine green excretion. Ann Surg 1996; 223:77-83.
34. Kusaka K, Imamura H, Tomiya T, Makuuchi M. Factors affecting liver regeneration after right portal vein embolization. Hepatogastroenterology 2004; 51:532-535. Following preoperative PVE, serum TGF-α levels and the nonembolized liver volume were examined in 18 patients. Hypertrophy of the nonembolized liver was associated with an increase in serum TGF-α at 14 days suggesting that its measurement may be helpful in planning subsequent hepatectomy.
35. Hirohashi K, Tanaka H, Tsukamoto T, et al. Limitation of portal vein embolization for extension of hepatectomy indication in patients with hepatocellular carcinoma. Hepatogastroenterology 2004; 51:1084-1087.
36. Kubo S, Shiomi S, Tanaka H, et al. Evaluation of the effect of portal vein embolization on liver function by (99m)tc-galactosyl human serum albumin scintigraphy. J Surg Res 2002; 107:113-118.
37. Lo CM, Fan ST, Liu CL, et al. Adult-to-adult living donor liver transplantation using extended right lobe grafts. Ann Surg 1997; 226:261-269.
38. Cattral MS, Molinari M, Vollmer CM Jr, et al. Living-donor right hepatectomy with or without inclusion of middle hepatic vein: comparison of morbidity and outcome in 56 patients. Am J Transplant 2004; 4:751-757. A prospective study comparing peri-operative outcome of 56 living liver donors with retention or removal of the MHV. No difference in outcome was observed between the two groups.
39. Lo CM, Fan ST, Liu CL, et al. Lessons learned from one hundred right lobe living donor liver transplants. Ann Surg 2004; 240:151-158.
40. Fan ST, Lo CM, Liu CL, et al. Determinants of hospital mortality of adult recipients of right lobe live donor liver transplantation. Ann Surg 2003; 238:864-869.
41. Emond JC, Renz JF, Ferrell LD, et al. Functional analysis of grafts from living donors. Implications for the treatment of older recipients. Ann Surg 1996; 224:544-552.
42. Nagino M, Ando M, Kamiya J, et al. Liver regeneration after major hepatectomy for biliary cancer. Br J Surg 2001; 88:1084-1091.
43. Williams RS, Alisa AA, Karani JB, et al. Adult-to-adult living donor liver transplant: UK experience. Eur J Gastroenterol Hepatol 2003; 15:7-14.
44. Kanematsu T, Takenaka K, Furuta T, et al. Acute portal hypertension associated with liver resection. Analysis of early postoperative death. Arch Surg 1985; 120:1303-1305.
45. Lee SS, Hadengue A, Girod C, et al. Reduction of intrahepatic vascular space in the pathogenesis of portal hypertension. In vitro and in vivo studies in the rat. Gastroenterology 1987; 93:157-161.
46. Gertsch P, Stipa F, Ho J, et al. Changes in hepatic portal resistance and in liver morphology during regeneration: in vitro study in rats. Eur J Surg 1997; 163:297-304.
47. Panis Y, McMullan DM, Emond JC. Progressive necrosis after hepatectomy and the pathophysiology of liver failure after massive resection. Surgery 1997; 121:142-149.
48. Gondolesi GE, Florman S, Matsumoto C, et al. Venous hemodynamics in living donor right lobe liver transplantation. Liver Transpl 2002; 8:809-813.
49. Smyrniotis V, Kostopanagiotou G, Kondi A, et al. Hemodynamic interaction between portal vein and hepatic artery flow in small-for-size split liver transplantation. Transpl Int 2002; 15:355-360.
50. Marcos A, Olzinski AT, Ham JM, et al. The interrelationship between portal and arterial blood flow after adult to adult living donor liver transplantation. Transplantation 2000; 70:1697-1703.
51. Man K, Fan ST, Lo CM, et al. Graft injury in relation to graft size in right lobe live donor liver transplantation: a study of hepatic sinusoidal injury in correlation with portal hemodynamics and intragraft gene expression. Ann Surg 2003; 237:256-264.
52. Man K, Lo CM, Ng IO, et al. Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. Arch Surg 2001; 136:280-285.
53. Clavien PA, Yadav S, Sindram D, Bentley RC. Protective effects of ischemic preconditioning for liver resection performed under inflow occlusion in humans. Ann Surg 2000; 232:155-162.
54. Clavien PA, Selzner M, Rudiger HA, et al. A prospective randomized study in 100 consecutive patients undergoing major liver resection with versus without ischemic preconditioning. Ann Surg 2003; 238:843-850. A prospective randomized study on 100 patients undergoing major liver resection to evaluate the impact of ischaemic preconditioning. Postoperative serum transaminase levels were significantly lower in preconditioned than in control patients, with increased benefit in younger patients, longer duration of inflow occlusion, where resected volume <50%, and in the presence of steatosis.
55. Franco-Gou R, Peralta C, Massip-Salcedo M, et al. Protection of reduced-size liver for transplantation. Am J Transplant 2004; 4:1408-1420.
56. Vajdova K, Heinrich S, Tian Y, et al. Ischemic preconditioning and intermittent clamping improve murine hepatic microcirculation and Kupffer cell function after ischemic injury. Liver Transpl 2004; 10:520-528.
57. Lo CM, Fan ST, Chan JK, et al. Minimum graft volume for successful adult-to-adult living donor liver transplantation for fulminant hepatic failure. Transplantation 1996; 62:696-698.
58. Paulsen AW, Klintmalm GB. Direct measurement of hepatic blood flow in native and transplanted organs, with accompanying systemic hemodynamics. Hepatology 1992; 16:100-111.
59. Garcia-Valdecasas JC, Fuster J, Charco R, et al. Changes in portal vein flow after adult living-donor liver transplantation: does it influence postoperative liver function? Liver Transpl 2003; 9:564-569.
60. Kato Y, Shimazu M, Wakabayashi G, et al. Significance of portal venous flow in graft regeneration after living related liver transplantation. Transplant Proc 2001; 33:1484-1485.
61. Ito T, Kiuchi T, Yamamoto H, et al. Changes in portal venous pressure in the early phase after living donor liver transplantation: pathogenesis and clinical implications. Transplantation 2003; 75:1313-1317. A prospective study measuring portal venous pressure (PVP) in 79 cases of LDLT. Recipients of SFS grafts had significantly higher PVP. Patients with elevated mean PVP early in the first week demonstrated significantly worse survival, and higher incidence of bacteremia, cholestasis, prolonged prothrombin time, and ascites. Splenic artery ligation effectively reduced PVP with improved survival.
62. Boillot O, Delafosse B, Mechet I, et al. Small-for-size partial liver graft in an adult recipient; a new transplant technique. Lancet 2002; 359:406-407.
63. Boillot O, Mechet I, Le Derf Y, et al. Portomesenteric disconnection for small-for-size grafts in liver transplantation: Preclinical studies in pigs. Liver Transpl 2003; 9:S42-S46.
64. Troisi R, Hoste E, Van Langenhove P, et al. Modulation of liver graft hemodynamics by partial ablation of the splenic circuit: a way to increase hepatic artery flow? Transplant Proc 2001; 33:1445-1446.
65. Troisi R, de Hemptinne B. Clinical relevance of adapting portal vein flow in living donor liver transplantation in adult patients. Liver Transpl 2003; 9:S36-S41. This article describes the technique and benefits of graft inflow modification (GIM) by splenic artery ligation in 24 consecutive adult to adult LDLT.
66. Sato Y, Yamamoto S, Oya H, et al. Splenectomy for reduction of excessive portal hypertension after adult living-related donor liver transplantation. Hepatogastroenterology 2002; 49:1652-1655.